Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-02-001752
Filing Date
2002-03-28
Accepted
2002-03-28 00:00:00
Documents
4
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 DATED 12/31/01 b42242aie10-k405.txt 10-K405 283277
3 SUBSIDIARIES OF THE COMPANY b42242aiex21-1.txt EX-21.1 341
4 CONSENT OF KPMG,LLP b42242aiex23-1.txt EX-23.1 1105
5 RISK FACTORS b42242aiex99-1.txt EX-99.1 33417
  Complete submission text file 0000950135-02-001752.txt   320009
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-29089 | Film No.: 02592328
SIC: 2836 Biological Products, (No Diagnostic Substances)